Initial Data Shows Covid-19 Vaccine Is More than 90% Effective


by kottke.org

kottke.org— In a press release (and not a paper in a peer-reviewed journal) based on a preliminary outside review of data from its phase 3 trial, Pfizer says its Covid-19 vaccine was more than 90% effective in preventing the disease. The company said that the analysis found that the vaccine was more than 90 percent effective in preventing the disease among trial volunteers who had no evidence of prior coronavirus infection. If the results hold up, that level of protection would put it on par with highly...

kottke.org—Oxford-AstraZeneca’s Covid-19 Vaccine Up to 90% Effective. Preliminary results from the trials of the Covid-19 vaccine jointly developed by the University of Oxford and AstraZeneca indicate that the vaccine’s overall efficacy is 70% but that a regimen that calls for a lower first dose is 90% effective. The preliminary results on the AstraZeneca vaccine were based on a total of 131 Covid-19 cases in a study involving 11,363 participants. The findings were perplexing. Two full doses of the vaccine appeared to be only 62% effective at preventing disease,...

kottke.org—Preliminary Results: Moderna Covid-19 Vaccine Is 94.5% Effective. Last Monday the world got some good news: an early review of the data showed that Pfizer’s Covid-19 vaccine was “more than 90% effective” in preventing the disease. The results pointed to other vaccines also being highly effective against the virus and this morning comes this news: Early Data Show Moderna’s Coronavirus Vaccine Is 94.5% Effective. The drugmaker Moderna announced on Monday that its coronavirus vaccine was 94.5 percent effective, based on an early look at the results from its...

www.i24news.tv—Report: Israel to procure, transfer millions of COVID-19 vaccines to Palestinians.